ETF DAILY NEWS

Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60

Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […]

Mar 31, 2025 - 06:15
 0
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60
Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […]
Read More

Tags:

Previous Article

SKK Holdings Limited’s (NASDAQ:SKK) Lock-Up Period Set To Expire on April 7th

Next Article

Brokerages Set Getty Realty Corp. (NYSE:GTY) Price Target at $33.60

Related Posts

Domo, Inc. (NASDAQ:DOMO) Receives $10.08 Consensus Target Price from Brokerages

Domo, Inc. (NASDAQ:DOMO) Receives $10.08 Consensus Targ...

Mar 11, 2025  0

Reinsurance Group of America, Incorporated (NYSE:RGA) Receives $229.62 Consensus Price Target from Brokerages

Reinsurance Group of America, Incorporated (NYSE:RGA) R...

Mar 8, 2025  0

Quantbot Technologies LP Purchases New Holdings in Lazard, Inc. (NYSE:LAZ)

Quantbot Technologies LP Purchases New Holdings in Laza...

Apr 1, 2025  0